Navigation Links
Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
Date:2/12/2008

WOBURN, Mass., Feb. 12 /PRNewswire/ -- AdvanDx announced it has named Else Beth Trautner, a former Executive Vice President of Dako A/S, as Vice President of Sales and Marketing. Ms. Trautner will aggressively drive the global adoption of AdvanDx's fast, accurate and easy-to-use in vitro molecular diagnostic products that advance the prevention, diagnosis and treatment of infectious pathogens. Ms. Trautner previously managed an organization of more than 575 employees with annual revenues in excess of $300 million at Dako, a global cancer diagnostics company, while successfully restructuring business operations in the Asia-Pacific region that led to record sales. Ms. Trautner also orchestrated the reorganization of 22 sales subsidiaries into 5 geographic regions resulting in 15% sales growth and a 9% increase in profitability during her tenure as Executive Vice President of Global Sales at Dako.

"Ms. Trautner is a seasoned executive with proven industry experience who will drive aggressive growth, market expansion, revenue production and ultimately profitability," said Thais T. Johansen, President and CEO of AdvanDx. "The addition of Ms. Trautner clearly positions AdvanDx to deliver our easy-to-use, life saving molecular diagnostic products worldwide to help treat patients afflicted with serious infections," Mr. Johansen added.

"I am pleased to join AdvanDx's strong business and scientific management team as we make significant inroads into multi-billion dollar markets," said Else Beth Trautner, Vice President of Sales and Marketing at AdvanDx. "I look forward to ramping our success in North America while opening up new markets, seizing revenue-generating sales opportunities and further accelerating the adoption of our products in the global marketplace," said Ms. Trautner.

About AdvanDx

AdvanDx is the world's leading provider of fast, accurate and easy-to-use in vitro molecular diagnostic products that advance the prevention, diagnosis and treatment of infectious pathogens. AdvanDx's products and services enable dramatic improvements in patient care and outcomes while reducing hospital costs.

Every year, 350,000 patients contract bloodstream infections, causing over 90,000 unnecessary deaths and significant costs to the healthcare system. The rapid identification of infecting pathogens is crucial to ensure early and appropriate therapy to save lives and reduce patient length-of-stay. In response, AdvanDx leverages its molecular diagnostic products to detect and identify infectious pathogens and provide therapy-directing results in hours versus days.

AdvanDx's easy-to-use products employ standard lab techniques and equipment to reduce startup, implementation, technician and maintenance time, while providing fast results without sacrificing accuracy. Major medical centers, reference labs, government institutions and community hospitals throughout the United States, Europe and Asia rely on AdvanDx products, supported by a global network of service partners.

For more information visit http://www.AdvanDx.com


'/>"/>
SOURCE AdvanDx
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Acrongenomics on Track to Acquire Molecular Vision
2. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
3. Acrongenomics Acquires Equity Stake in Molecular Vision
4. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
5. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
6. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
7. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
8. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
9. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
10. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
11. Center for Molecular Medicine Among First Labs in Nation to Offer Groundbreaking Test to Aid in Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology:
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):